• Mashup Score: 0
    Medable at DIA 2023 - 1 year(s) ago

    Join us for our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the latest industry research, and pick up Medable swag.

    Tweet Tweets with this article
    • At #DIA2023 join us to discover how & why leading pharma companies are using online platforms to deliver drug development transformation at scale. Explore the evolving regulatory guidance & latest research validating that DCTs are here to stay. Learn more: https://t.co/6vc0P7xwFo https://t.co/M4TYxhbUal

  • Mashup Score: 0

    Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote Data Collection, and Data Oversight. Best practices for the ethical review, approval, and conduct of DCTs will be provided.

    Tweet Tweets with this article
    • Join us on June 20, from 10–11am ET, for a joint webinar with @MRCTCenter 'Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources, and Best Practices'. We invite all #clinicaltrial stakeholders to join. Register here: https://t.co/0szoN1xMOd https://t.co/e9XcRYCTwx

  • Mashup Score: 1

    Along with some of the best companies in the world, Medable is proud to join CancerX as a founding member. This alliance is co-hosted by the Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).

    Tweet Tweets with this article
    • Medable is proud to join @CancerXMoonshot as a founding member. Together, this group will foster a large community of patients, advocates, researchers, and clinicians who look to halve the cancer death rate within 25 years. Learn more: https://t.co/n4hDtmuYlq

  • Mashup Score: 0
    Medable at DIA 2023 - 2 year(s) ago

    Join us for our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the latest industry research, and pick up Medable swag.

    Tweet Tweets with this article
    • Team Medable is excited for DIA 2023! Join us at booth #339 to learn about digital clinical solutions that offer patients more freedom, improve diversity in research, and deliver actionable outcomes for lifesaving treatments. Book some time with us here: https://t.co/6vc0P7xwFo

  • Mashup Score: 1

    DAY 1 – June 6, 2023 Closing the Acceptance Gap on Decentralised Clinical Trials 9am EST / 2pm BST / 3pm CEST Looking at the various personas a decentralized trial engages with we will look at the barriers to participation/adoption. We will have a call to action from a sponsor, CRO and regulatory space to help continuing to drive…

    Tweet Tweets with this article
    • 🚨🚨 DCT Digital Week is almost here!! Join Medable's webcast with our panel of experts who'll discuss how sponsors & CROs can scale their clinical trial conduct to the next level to achieve their organizational goals. Register here: https://t.co/J1YUmtZilb ___ #clinicaltrials https://t.co/KFI2Fs739N

  • Mashup Score: 1

    The recent release (May 2023) of the FDA’s Decentralized Clinical Trial (DCT) Draft Guidance has sparked a wave of excitement and anticipation within the field of clinical trials. This long-awaited guidance represents a significant milestone in the evolution of clinical trial methodologies, signaling clear support for the global shift towards expanded trial models. This guidance reinforces the…

    Tweet Tweets with this article
    • Medable's Pamela Tenaerts, CSO; Kevin Potgieter, VP Regulatory; & Mohammed Ali, CDO, provide their perspectives on the recent FDA draft guidance for DCTs. Read here: https://t.co/zFTGMDiHuF _______ #clinicaltrials #clinicalresearch #healthcare #decentralizedtrials

  • Mashup Score: 0

    Despite years of effort, health data remains fragmented across institutions, sectors, and companies. There is no standardized way to collect or store non-individualized patient data; potentially useful information from personal devices often goes unleveraged. Lacking a clear framework, researchers and regulators are uncertain how to integrate real-world data into their work. With the data siloed,…

    Tweet Tweets with this article
    • ICYMI: An all-star panel recently discussed what clinical data systems of the future should look like at the @MilkenInstitute Global Conference 🗣️. Find out more, here: https://t.co/MtDiMlHebI ______ #clinicaltrials #MIGlobal @LongmireMD https://t.co/LQzlqCZaxi

  • Mashup Score: 0

    The new FDA Patient Focused Drug Development (PFDD) Guidance Series and the Core Patient-Reported Outcomes Measures (PROMs) in Cancer Clinical Trials Guidance demonstrates the industry’s commitment to optimizing clinical trial design, presenting the opportunity to minimize participant and site burden. Traditionally, oncology trials have been solely site-based, with lengthy, complex, and…

    Tweet Tweets with this article
    • OD webinar: Flo Mowlem & Dagmara Kulis share insights on how digital solutions, with a focus on electronic patient-reported outcome (ePROs), can reduce burdens for participants & sites to maximize the chance of oncology study success. Watch now: https://t.co/tRUTjOvdjt https://t.co/94gz4Pc0VK